Comprehensive and integrated CRDMO platform for recombinant proteins and peptide therapeutics
GMP-compliant one-stop CRDMO platform for plasmid development, commercial manufacturing, and regulatory submission
Microbial recombinant expression systems providing integrated, end-to-end nano-body CRDMO services
Focusing on microbial expression systems, with comprehensive development of diverse recombinant vaccines (VLP and DNA vaccines)
One-stop mRNA CRO Solutions, delivering research-grade custom mRNA synthesis services
High-quality circRNA custom services covering the full lifecycle of research-grade circRNA sample preparation and quality control
Yaohai Bio-Pharma delivers tailored solutions for global clients, meeting diverse project requirements with excellence and efficiency.
Proven track record of over 100 successful projects, spanning preclinical studies and Phase I/II/III clinical trials, including US–China dual submissions and Australian regulatory filings.
A robust GMP-aligned quality system with standardized SOPs, fully compliant with global regulatory guidelines across the entire product lifecycle.
Powered by industry-leading scientists and cross-functional experts, our team delivers CRDMO projects with speed, precision, and deep technical insight.